Journal List > J Korean Ophthalmol Soc > v.60(7) > 1129785

Jung, Lee, and Bae: Comparison of Myopic Progression before and after Orthokeratology Lens Treatment

Abstract

Purpose

To compare the myopic progression before and after wearing an orthokeratology lens (OK).

Methods

Twenty-six patients (49 eyes) with at least 6 months of myopia prior to OK treatment were evaluated. Changes in the spherical equivalent (SE) refractive error and axial length were compared before and after OK use. Changes in the SE and axial length were also compared between two groups according to the myopic progression before baseline: Group 1 with myopic progression < 1 D/year and Group 2 with myopic progression > 1 D/year.

Results

The myopic progression rate decreased from −1.1 to −0.3 D/year after OK treatment (p < 0.001). Greater increases in axial length were observed in patients who were younger and had less myopia at baseline, a higher rate of myopia progression before baseline, and a shorter axial length at baseline (p < 0.001, p < 0.004, p < 0.007, and p < 0.001, respectively). The increase in axial length was significantly greater in the group with greater myopic progression before baseline (0.2 mm/year) than in the group with less myopic progression (0.1 mm/year) (p = 0.001).

Conclusions

Myopic progression was reduced significantly after OK treatment.

Figures and Tables

Figure 1

Myopic progression rates of before and after orthokeratology lens (OK) treatment. The mean myopic progression rate from diagnosis to OK (before OK) is −1.1 D/year, which is significantly higher than −0.3 D/year from OK to last follow up (after OK) (*p < 0.001, Wilcoxon Signed-Rank test). The mean myopic progression of 1 year before OK is −1.1 D, which is significantly higher than −0.2 D in 1 year after OK (*p < 0.001, Wilcoxon Signed-Rank test).

jkos-60-620-g001
Figure 2

Increase in axial length and age at orthokeratology lens (OK), spherical equivalent refractive error (SE) at OK, SE change (diopter, D)/year and axial length at OK. Significant correlations were found between increase in axial length and age at OK, SE at OK, SE change (D)/year and axial length at OK (Pearson's correlation coefficient, r = −0.482; p < 0.001, r = 0.409; p = 0.004, r = −0.380; p = 0.007, r = −0.554; p < 0.001).

jkos-60-620-g002
Table 1

Baseline characteristics of subjects

jkos-60-620-i001

Values are presented as mean ± standard deviation (range) unless otherwise indicated.

SE = spherical equivalent refractive error; D = diopter; OK = orthokeratology lens.

Table 2

Comparison between 2 groups according to the myopic progression before orthokeratology treatment

jkos-60-620-i002

Values are presented as mean ± standard deviation (range). ‘Group 1’ means myopic progression rate less than 1 D/year. ‘Group 2’ means myopic progression rate more than 1 D/year.

SE = spherical equivalent refractive error; D = diopter; OK = orthokeratology lens.

*Two sample t-test; Mann Whitney U-test.

Table 3

Comparison between 2 groups according to the age at orthokeratology lens treatment

jkos-60-620-i003

Values are presented as mean ± standard deviation (range). ‘Group 1’ means age at orthokeratology lens <10 years. ‘Group 2’ means age at orthokeratology lens ≥10 years.

SE = spherical equivalent refractive error; D = diopter; OK = orthokeratology lens.

*Two sample t-test;Mann Whitney U-test.

Notes

Conflicts of Interest The authors have no conflicts to disclose.

References

1. Fan DS, Lam DS, Lam RF, et al. Prevalence, incidence, and progression of myopia of school children in Hong Kong. Invest Ophthalmol Vis Sci. 2004; 45:1071–1075.
crossref
2. Li SM, Li SY, Kang MT, et al. Near work related parameters and myopia in Chinese children: the Anyang childhood eye study. PLoS One. 2015; 10:e0134514.
crossref
3. Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 2005; 30:71–80.
crossref
4. Walline JJ, Jones LA, Sinnott LT. Corneal reshaping and myopia progression. Br J Ophthalmol. 2009; 93:1181–1185.
crossref
5. Kakita T, Hiraoka T, Oshika T. Influence of overnight orthokeratology on axial elongation in childhood myopia. Invest Ophthalmol Vis Sci. 2011; 52:2170–2174.
crossref
6. Hiraoka T, Kakita T, Okamoto F, et al. Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci. 2012; 53:3913–3919.
crossref
7. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Factors preventing myopia progression with orthokeratology correction. Optom Vis Sci. 2013; 90:1225–1236.
crossref
8. Charm J, Cho P. High myopia-partial reduction ortho-k: a 2-year randomized study. Optom Vis Sci. 2013; 90:530–539.
9. Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012; 53:7077–7085.
crossref
10. Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci. 2013; 54:6510–6517.
crossref
11. Saw SM, Shankar A, Tan SB, et al. A cohort study of incident myopia in Singaporean children. Invest Ophthalmol Vis Sci. 2006; 47:1839–1844.
crossref
12. Mutti DO, Mitchell GL, Moeschberger ML, et al. Parental myopia, near work, school achievement, and children's refractive error. Invest Ophthalmol Vis Sci. 2002; 43:3633–3640.
13. Hammond CJ, Snieder H, Gilbert CE, Spector TD. Genes and environment in refractive error: the twin eye study. Invest Ophthalmol Vis Sci. 2001; 42:1232–1236.
14. Swarbrick HA, Alharbi A, Watt K, et al. Myopia control during orthokeratology lens wear in children using a novel study design. Ophthalmology. 2015; 122:620–630.
crossref
15. Chan KY, Cheung SW, Cho P. Orthokeratology for slowing myopic progression in a pair of identical twins. Cont Lens Anterior Eye. 2014; 37:116–119.
crossref
16. Hyman L, Gwiazda J, Hussein M, et al. Relationship of age, sex, and ethnicity with myopia progression and axial elongation in the correction of myopia evaluation trial. Arch Ophthalmol. 2005; 123:977–987.
crossref
TOOLS
Similar articles